Treatment planning algorithm for peptide receptor radionuclide therapy considering multiple tumor lesions and organs at risk-Reference-Cited by-同舟云学术

Treatment planning algorithm for peptide receptor radionuclide therapy considering multiple tumor lesions and organs at risk

Published:2018-07-13 Issue:8 Volume:45 Page:3516-3523
ISSN:0094-2405
Container-title:Medical Physics
language:en
Short-container-title:Med. Phys.

Author:

Jiménez-Franco Luis David¹²,Kletting Peter³⁴,Beer Ambros J.⁴,Glatting Gerhard³⁴

Affiliation:

1. Medical Radiation Physics/Radiation Protection; Universitätsmedizin Mannheim; Medical Faculty Mannheim; Heidelberg University; Mannheim D-68167 Germany

2. Department of Radiation Oncology; Universitätsmedizin Mannheim; Medical Faculty Mannheim; Heidelberg University; Mannheim D-68167 Germany

3. Medical Radiation Physics; Department of Nuclear Medicine; Ulm University; Ulm 89081 Germany

4. Department of Nuclear Medicine; Ulm University; Ulm 89081 Germany

Funder

Seventh Framework Programme

M²OLIE

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mp.13049/fullpdf

Reference35 articles.

1. Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake;Seystahl;Neuro Oncol,2016

2. Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma;Kreissl;Radiat Oncol,2012

3. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours;Bodei;Eur J Nucl Med Mol Imaging,2013

4. Optimized peptide amount and activity for 90Y-labeled DOTATATE therapy;Kletting;J Nucl Med,2016

5. Peptide receptor radionuclide therapy: an overview;Dash;Cancer Biother Radiopharm,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-Informed Radiopharmaceutical Therapy Optimization: A Study on the Impact of PBPK Model Parameters on Physical, Biological, and Statistical Measures in 177Lu-PSMA Therapy;Cancers;2024-09-10

2. A PBPK model for PRRT with [177Lu]Lu-DOTA-TATE: Comparison of model implementations in SAAM II and MATLAB/SimBiology;Physica Medica;2024-03

3. Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [¹⁷⁷Lu]Lu-PSMA-617 Therapy;Journal of Nuclear Medicine;2024-02-29

4. A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients;EJNMMI Research;2023-02-03

5. Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy;EJNMMI Research;2022-12-19